Abstract:Background Depression is a prevalent mental disorder that is undiagnosed and untreated in half of all cases. Wearable activity trackers collect fine-grained sensor data characterizing the behavior and physiology of users (ie, digital biomarkers), which could be used for timely, unobtrusive, and scalable depression screening. Objective The aim of this study was to examine the predictive ability of digital biomarkers, based on sensor data from consumer-grade wearables, to detect risk of depression in a working population. Methods This was a cross-sectional study of 290 healthy working adults. Participants wore Fitbit Charge 2 devices for 14 consecutive days and completed a health survey, including screening for depressive symptoms using the 9-item Patient Health Questionnaire (PHQ-9), at baseline and 2 weeks later. We extracted a range of known and novel digital biomarkers characterizing physical activity, sleep patterns, and circadian rhythms from wearables using steps, heart rate, energy expenditure, and sleep data. Associations between severity of depressive symptoms and digital biomarkers were examined with Spearman correlation and multiple regression analyses adjusted for potential confounders, including sociodemographic characteristics, alcohol consumption, smoking, self-rated health, subjective sleep characteristics, and loneliness. Supervised machine learning with statistically selected digital biomarkers was used to predict risk of depression (ie, symptom severity and screening status). We used varying cutoff scores from an acceptable PHQ-9 score range to define the depression group and different subsamples for classification, while the set of statistically selected digital biomarkers remained the same. For the performance evaluation, we used k-fold cross-validation and obtained accuracy measures from the holdout folds. Results A total of 267 participants were included in the analysis. The mean age of the participants was 33 (SD 8.6, range 21-64) years. Out of 267 participants, there was a mild female bias displayed (n=170, 63.7%). The majority of the participants were Chinese (n=211, 79.0%), single (n=163, 61.0%), and had a university degree (n=238, 89.1%). We found that a greater severity of depressive symptoms was robustly associated with greater variation of nighttime heart rate between 2 AM and 4 AM and between 4 AM and 6 AM; it was also associated with lower regularity of weekday circadian rhythms based on steps and estimated with nonparametric measures of interdaily stability and autocorrelation as well as fewer steps-based daily peaks. Despite several reliable associations, our evidence showed limited ability of digital biomarkers to detect depression in the whole sample of working adults. However, in balanced and contrasted subsamples comprised of depressed and healthy participants with no risk of depression (ie, no or minimal depressive symptoms), the model achieved an accuracy of 80%, a sensitivity of 82%, and a specificity of 78% in detecting subjects at high risk of depression. Conclusions Digital biomarkers that have been discovered and are based on behavioral and physiological data from consumer wearables could detect increased risk of depression and have the potential to assist in depression screening, yet current evidence shows limited predictive ability. Machine learning models combining these digital biomarkers could discriminate between individuals with a high risk of depression and individuals with no risk.

A narrative review of digital biomarkers in the management of major depressive disorder and treatment-resistant forms

A narrative review of digital biomarkers in the management of major depressive disorder and treatment-resistant forms

Digital Phenotyping for Differential Diagnosis of Major Depressive Episode: Narrative Review

Digital biomarkers in depression: A systematic review and call for standardization and harmonization of feature engineering

Digital Biomarkers for Depression Screening With Wearable Devices: Cross-sectional Study With Machine Learning Modeling

From smartphone data to clinically relevant predictions: A systematic review of digital phenotyping methods in depression

Digital phenotype of mood disorders: A conceptual and critical review

Digital technology and clinical decision making in depression treatment: Current findings and future opportunities

Clinical Targets and Attitudes Toward Implementing Digital Health Tools for Remote Measurement in Treatment for Depression: Focus Groups With Patients and Clinicians

Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine

[Application Progress of Wearable Devices in the Field of Depression Monitoring and Intervention]

Systematic review and meta-analysis of performance of wearable artificial intelligence in detecting and predicting depression

A Comprehensive Review on Harnessing Wearable Technology for Enhanced Depression Treatment

Digital Psychotherapies for Adults Experiencing Depressive Symptoms: Systematic Review and Meta-Analysis

Predicting treatment outcome in depression: an introduction into current concepts and challenges

CBT-informed psychological interventions for adult patients with anxiety and depression symptoms: A narrative review of digital treatment options

Digital biomarkers of mood disorders and symptom change

Digital Tools to Facilitate the Detection and Treatment of Bipolar Disorder: Key Developments and Future Directions

Digital health technology for use in patients with serious mental illness: a systematic review of the literature

A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder

The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder